Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Royal KPN N.V. Press Release: KPN reports on progress of € 300m share buyback
Ørsted completes onshore wind farm Haystack Wind in Nebraska
Ørsted completes onshore wind farm Haystack Wind in Nebraska
Ørsted completes onshore wind farm Haystack Wind in Nebraska
DGAP-News: Mynaric exhibiting, presenting and holding  live demo at SATELLITE 2022
DGAP-News: Mynaric exhibiting, presenting and holding live demo at SATELLITE 2022
DGAP-News: Mynaric exhibiting, presenting and holding live demo at SATELLITE 2022
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Pearson plc
Form 8.3 - The Vanguard Group, Inc.: Pearson plc
Form 8.3 - The Vanguard Group, Inc.: Pearson plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: GXO Logistics, Inc.
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
DGAP-Adhoc: Gateway Real Estate AG: Forecast for the fiscal year 2022
DGAP-Adhoc: Gateway Real Estate AG: Forecast for the fiscal year 2022
DGAP-Adhoc: Gateway Real Estate AG: Forecast for the fiscal year 2022
Employee representatives elected to the Board of Directors of Ørsted A/S
Employee representatives elected to the Board of Directors of Ørsted A/S
Employee representatives elected to the Board of Directors of Ørsted A/S
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
Aroundtown SA: Release of a capital market information
DGAP-News: Deutsche Rohstoff AG: Terms agreed for lithium exploration in Western Australia and establishment of a lithium subsidiary
DGAP-News: Deutsche Rohstoff AG: Terms agreed for lithium exploration in Western Australia and establishment of a lithium subsidiary
DGAP-News: Deutsche Rohstoff AG: Terms agreed for lithium exploration in Western Australia and establishment of a lithium subsidiary
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
SThree: Q1 Trading Update
SThree: Q1 Trading Update
SThree: Q1 Trading Update
Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales
Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales
Relief Therapeutics Appoints Christopher Wick as Senior Director, Head of U.S. Sales
Mobimo Holding AG: Mobimo plans capital increase to continue its growth strategy
Mobimo Holding AG: Mobimo plans capital increase to continue its growth strategy
Mobimo Holding AG: Mobimo plans capital increase to continue its growth strategy
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Relief Therapeutics Files Amendment No. 1 to its Registration Statement on Form 20-F with the U.S. Securities and Exchange Commission
Course set for the future. All motions passed with large majority
Course set for the future. All motions passed with large majority
Course set for the future. All motions passed with large majority
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) FY 2021 Financial Results
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) FY 2021 Financial Results
Orascom Development Holding AG: announces its Egyptian Subsidiary (ODE) FY 2021 Financial Results
EQS-News: AGTech Announces 2021 Annual Results
EQS-News: AGTech Announces 2021 Annual Results
EQS-News: AGTech Announces 2021 Annual Results
DGAP-News: exceet Group SCA:  Financial Results 2021 (Annual Report)
DGAP-News: exceet Group SCA: Financial Results 2021 (Annual Report)
DGAP-News: exceet Group SCA: Financial Results 2021 (Annual Report)
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board
DGAP-News: Vita 34 sets course for accelerated growth in new business areas with changes in the Management Board